Copyright © 2008 ISDN Published by Elsevier Ltd.
Oligomeric β-amyloid(1-42) induces the expression of Alzheimer disease-relevant proteins in cholinergic SN56.B5.G4 cells as revealed by proteomic analysis
Received 7 December 2007;
References and further reading may be available for this article. To view references and further reading you must purchase this article.
Abstract
Alzheimer's disease (AD) is characterized by cholinergic dysfunction and progressive basal forebrain cell loss which has been hypothesized to be associated with extensive accumulation of β-amyloid (Aβ). To reveal whether oligomeric Aβ displays a particular toxicity for cholinergic neurons, the cholinergic cell line SN56.B5.G4 (SN56) was used as a model. Recently performed microarray analyses demonstrated that genes affected by exposure of SN56 cells with 50 μM oligomeric Aβ(1-42) for 24 h were involved in protein modification and degradation [Heinitz, K., Beck, M., Schliebs, R., Perez-Polo, J.R., 2006. Toxicity mediated by soluble oligomers of beta-amyloid(1-42) on cholinergic SN56.B5.G4 cells. J. Neurochem. 98, 1930–1945]. Using a proteomic approach, we compared the levels of proteins and specially of phosphorylated proteins in cytosolic fractions of cell lysates from cholinergic SN56 cells exposed to 50 μM Aβ(1-42) for 24 h to those in control incubations. We show here that the levels of calreticulin, and mitogen-activated protein kinase (MAPK) kinase 6c were up-regulated in cholinergic SN56 cells exposed to Aβ(1-42), while γ-actin appeared down-regulated. Aβ(1-42) exposure of cholinergic SN56 cells led to decreased phosphorylation of phosphoproteins, such as the Rho GDP dissociation inhibitor, the ubiquitin carboxyl terminal hydrolase-1, and the tubulin α-chain isotype Mα6, as compared to untreated control lysates. The proteins identified have also been reported to be affected in brains of AD patients, suggesting a potential role of Aβ in influencing the integrity and functioning of the proteome in AD.
Keywords: Cholinergic cell culture; Beta-amyloid toxicity; Alzheimer-relevant proteins; Mass spectrometry; Two-dimensional electrophoresis; Protein identification; Proteomics
Abbreviations: Aβ(1-42), β-amyloid(1-42) peptide; AD, Alzheimer's disease; SN56, SN56.B5.G4 cholinergic cell line; 2D PAGE, two-dimensional polyacrylamide gel electrophoresis; MALDI-TOF, matrix-assisted laser desorption/ionization time-of-flight; MAPK, mitogen-activated protein kinase; RuBPS, Ruthenium-II-Tris(Bathophenanthrolin disulphonate)
Article Outline
- 1. Introduction
- 2. Materials and methods
- 2.1. Cell culture
- 2.2. Treatment of cells and protein extraction
- 2.3. Two-dimensional gel electrophoresis
- 2.4. Image analysis
- 2.5. Sample preparation for mass spectrometry
- 2.6. Protein identification using MALDI-TOF-mass spectrometry and database searching
- 3. Results
- 3.1. Identification of proteins in cell lysates of cholinergic SN56 cells, affected by exposure to Aβ(1-42)
- 3.2. Identification of phosphorylated proteins in cell lysates of SN56 cells after Aβ(1-42) treatment
- 4. Discussion
- Acknowledgements
- References







E-mail Article
Add to my Quick Links

Cited By in Scopus (0)






